Trial Outcomes & Findings for Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (NCT NCT01602536)

NCT ID: NCT01602536

Last Updated: 2024-10-31

Results Overview

self-reported 7-day point prevalence abstinence from smoking that was sustained at 60 days after the quit date, based on survey

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

160 participants

Primary outcome timeframe

60 days after quit date

Results posted on

2024-10-31

Participant Flow

Participant milestones

Participant milestones
Measure
Twitter
Experimental participants are assigned a 20-person twitter quit-smoking group to interact with, are instructed to use Twitter-enabled interactive peer messaging,and are sent daily messages to encourage interaction. The baseline intervention 'smoking cessation aides' is also provided. smoking cessation aides: All participants will receive 8 weeks of free nicotine patches, referral to the NCI's online Smokefree.gov Quit Guide, and instruction to set a quit date within 8 days of study start. Twitter: Twitter quit-smoking group
Control
Control participants are not assigned to a twitter group. The baseline intervention 'smoking cessation aides' is also provided. smoking cessation aides: All participants will receive 8 weeks of free nicotine patches, referral to the NCI's online Smokefree.gov Quit Guide, and instruction to set a quit date within 8 days of study start.
Overall Study
STARTED
80
80
Overall Study
COMPLETED
65
70
Overall Study
NOT COMPLETED
15
10

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Twitter-enabled Mobile Messaging for Smoking Relapse Prevention

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Twitter
n=80 Participants
Experimental participants are assigned a 20-person twitter quit-smoking group to interact with, are instructed to use Twitter-enabled interactive peer messaging,and are sent daily messages to encourage interaction. The baseline intervention 'smoking cessation aides' is also provided. smoking cessation aides: All participants will receive 8 weeks of free nicotine patches, referral to the NCI's online Smokefree.gov Quit Guide, and instruction to set a quit date within 8 days of study start. Twitter: Twitter quit-smoking group
Control
n=80 Participants
Control participants are not assigned to a twitter group. The baseline intervention 'smoking cessation aides' is also provided. smoking cessation aides: All participants will receive 8 weeks of free nicotine patches, referral to the NCI's online Smokefree.gov Quit Guide, and instruction to set a quit date within 8 days of study start.
Total
n=160 Participants
Total of all reporting groups
Age, Continuous
age
35.35 years
STANDARD_DEVIATION 10.55 • n=5 Participants
36.00 years
STANDARD_DEVIATION 9.16 • n=7 Participants
35.68 years
STANDARD_DEVIATION 9.85 • n=5 Participants
Sex: Female, Male
Female
55 Participants
n=5 Participants
61 Participants
n=7 Participants
116 Participants
n=5 Participants
Sex: Female, Male
Male
25 Participants
n=5 Participants
19 Participants
n=7 Participants
44 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 60 days after quit date

self-reported 7-day point prevalence abstinence from smoking that was sustained at 60 days after the quit date, based on survey

Outcome measures

Outcome measures
Measure
Twitter
n=65 Participants
Experimental participants are assigned a 20-person twitter quit-smoking group to interact with, are instructed to use Twitter-enabled interactive peer messaging,and are sent daily messages to encourage interaction. The baseline intervention 'smoking cessation aides' is also provided. smoking cessation aides: All participants will receive 8 weeks of free nicotine patches, referral to the NCI's online Smokefree.gov Quit Guide, and instruction to set a quit date within 8 days of study start. Twitter: Twitter quit-smoking group
Control
n=70 Participants
Control participants are not assigned to a twitter group. The baseline intervention 'smoking cessation aides' is also provided. smoking cessation aides: All participants will receive 8 weeks of free nicotine patches, referral to the NCI's online Smokefree.gov Quit Guide, and instruction to set a quit date within 8 days of study start.
Self-reported 7-day Point Prevalence Abstinence From Smoking That Was Sustained at 60 Days After the Quit Date
26 Participants
14 Participants

SECONDARY outcome

Timeframe: 100 days total

Population: all participants were observed to assess their tweeting (posting) behavior

level of engagement based on tweet volume which is observed in support groups

Outcome measures

Outcome measures
Measure
Twitter
n=80 Participants
Experimental participants are assigned a 20-person twitter quit-smoking group to interact with, are instructed to use Twitter-enabled interactive peer messaging,and are sent daily messages to encourage interaction. The baseline intervention 'smoking cessation aides' is also provided. smoking cessation aides: All participants will receive 8 weeks of free nicotine patches, referral to the NCI's online Smokefree.gov Quit Guide, and instruction to set a quit date within 8 days of study start. Twitter: Twitter quit-smoking group
Control
n=80 Participants
Control participants are not assigned to a twitter group. The baseline intervention 'smoking cessation aides' is also provided. smoking cessation aides: All participants will receive 8 weeks of free nicotine patches, referral to the NCI's online Smokefree.gov Quit Guide, and instruction to set a quit date within 8 days of study start.
Level of Engagement Based on Tweet Volume
58.86 social media posts
Standard Deviation 68.02
0 social media posts
Standard Deviation 0

Adverse Events

Twitter

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Cornelia Pechmann

University of California, Irvine

Phone: 310-892-0619

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place